These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 22248133

  • 21. [Parkinson's disease].
    Yokochi M.
    Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):5-14. PubMed ID: 10434578
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Dopamine dysregulation syndrome in Parkinson's disease: case report.
    Kummer A, Maia DP, Salgado JV, Cardoso FE, Teixeira AL.
    Arq Neuropsiquiatr; 2006 Dec; 64(4):1019-22. PubMed ID: 17221016
    [Abstract] [Full Text] [Related]

  • 26. Recent advances in pharmacological therapy of Parkinson's disease.
    Riederer P, Lange KW, Youdim MB.
    Adv Neurol; 1993 Dec; 60():626-35. PubMed ID: 8093582
    [Abstract] [Full Text] [Related]

  • 27. [Behavioral disorders in Parkinson's disease: from pathophysiology to the mastery of dopaminergic treatment].
    Thobois S, Ardouin C, Schmitt E, Lhommée E, Klinger H, Xie J, Lagrange C, Kistner A, Aya Kombo M, Fleury V, Poisson A, Fraix V, Broussolle E, Pollak P, Krack P.
    Rev Neurol (Paris); 2010 Oct; 166(10):816-21. PubMed ID: 20739041
    [Abstract] [Full Text] [Related]

  • 28. Resolution of dopamine dysregulation syndrome following cessation of dopamine agonist therapy in Parkinson's disease.
    Kimber TE, Thompson PD, Kiley MA.
    J Clin Neurosci; 2008 Feb; 15(2):205-8. PubMed ID: 18068992
    [Abstract] [Full Text] [Related]

  • 29. [Hypersexuality during use of levodopa].
    van Deelen RA, Rommers MK, Eerenberg JG, Egberts AC.
    Ned Tijdschr Geneeskd; 2002 Nov 02; 146(44):2095-8. PubMed ID: 12448966
    [Abstract] [Full Text] [Related]

  • 30. Recent advances in Parkinson's disease.
    Vécsei L.
    Ideggyogy Sz; 2002 Nov 20; 55(11-12):406-7. PubMed ID: 12632802
    [No Abstract] [Full Text] [Related]

  • 31. Hypersexuality due to dopaminergic drugs.
    Prescrire Int; 2005 Dec 20; 14(80):224. PubMed ID: 16400746
    [Abstract] [Full Text] [Related]

  • 32. Dopaminergic dysregulation syndrome in Parkinson's disease.
    Katzenschlager R.
    J Neurol Sci; 2011 Nov 15; 310(1-2):271-5. PubMed ID: 21868039
    [Abstract] [Full Text] [Related]

  • 33. Clinical pharmacology of levodopa-induced dyskinesia in parkinsonian patients.
    Rascol O, Brefel-Courbon C, Descombes S, Montastruc JL.
    Adv Neurol; 1999 Nov 15; 80():485-90. PubMed ID: 10410760
    [No Abstract] [Full Text] [Related]

  • 34. Levodopa addiction in idiopathic Parkinson disease.
    Borek LL, Friedman JH.
    Neurology; 2005 Nov 08; 65(9):1508. PubMed ID: 16275855
    [No Abstract] [Full Text] [Related]

  • 35. [Drug therapy of Parkinson's disease].
    Myllylä V.
    Duodecim; 1997 Nov 08; 113(18):1827-34. PubMed ID: 10892076
    [No Abstract] [Full Text] [Related]

  • 36. Progress in Parkinson's disease.
    Schapira AH.
    Eur J Neurol; 2008 Jan 08; 15(1):1. PubMed ID: 18171385
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Sleep disorders in Parkinson's disease.
    Larsen JP.
    Adv Neurol; 2003 Jan 08; 91():329-34. PubMed ID: 12442690
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.